Lipid-Based Nanomedicines for Type-Specific Ovarian CancerLipid-Based Nanomedicines for Type-Specific Ovarian Cancer
Epithelial ovarian cancers are currently all treated with the same chemotherapeutic regimen, but delivery via lipid-based nanoparticles has the potential to allow greater specificity by cancer subtype. Nanomedicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Health | Nanotechnology | Ovarian Cancer | Ovaries | Pathology